BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14648772)

  • 1. Resonance Raman scattering of cytochrome P450 BM3 and effect of imidazole inhibitors.
    Smith SJ; Munro AW; Smith WE
    Biopolymers; 2003 Dec; 70(4):620-7. PubMed ID: 14648772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of nitric oxide with cytochrome P450 BM3.
    Quaroni LG; Seward HE; McLean KJ; Girvan HM; Ost TW; Noble MA; Kelly SM; Price NC; Cheesman MR; Smith WE; Munro AW
    Biochemistry; 2004 Dec; 43(51):16416-31. PubMed ID: 15610036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phe393 mutants of cytochrome P450 BM3 with modified heme redox potentials have altered heme vinyl and propionate conformations.
    Chen Z; Ost TW; Schelvis JP
    Biochemistry; 2004 Feb; 43(7):1798-808. PubMed ID: 14967021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observation of ligand binding to cytochrome P450 BM-3 by means of solid-state NMR spectroscopy.
    Jovanovic T; McDermott AE
    J Am Chem Soc; 2005 Oct; 127(40):13816-21. PubMed ID: 16201802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein dynamics and imidazole binding in cytochrome P450 enzymes.
    Verras A; Ortiz de Montellano PR
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1170-2. PubMed ID: 17073778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P450 versus P420: correlation between cyclic voltammetry and visible absorption spectroscopy of the immobilized heme domain of cytochrome P450 BM3.
    Panicco P; Astuti Y; Fantuzzi A; Durrant JR; Gilardi G
    J Phys Chem B; 2008 Nov; 112(44):14063-8. PubMed ID: 18842012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic characterization of the iron-oxo intermediate in cytochrome P450.
    Jung C; Schünemann V; Lendzian F; Trautwein AX; Contzen J; Galander M; Böttger LH; Richter M; Barra AL
    Biol Chem; 2005 Oct; 386(10):1043-53. PubMed ID: 16218876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetry properties of vibrational modes in mesoporphyrin IX dimethyl ester investigated by polarization-sensitive resonance Raman and CARS spectroscopy.
    Koster J; Popp J; Kiefer W; Schlücker S
    J Phys Chem A; 2006 Oct; 110(39):11252-9. PubMed ID: 17004734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitration of internal tyrosine of cytochrome c probed by resonance Raman scattering.
    Quaroni L; Smith WE
    Biospectroscopy; 1999; 5(5 Suppl):S71-6. PubMed ID: 10512540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural rationalization of novel drug metabolizing mutants of cytochrome P450 BM3.
    Stjernschantz E; van Vugt-Lussenburg BM; Bonifacio A; de Beer SB; van der Zwan G; Gooijer C; Commandeur JN; Vermeulen NP; Oostenbrink C
    Proteins; 2008 Apr; 71(1):336-52. PubMed ID: 17957765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CO photodissociation dynamics in cytochrome P450BM3 studied by subpicosecond visible and mid-infrared spectroscopy.
    Rupenyan A; Commandeur J; Groot ML
    Biochemistry; 2009 Jul; 48(26):6104-10. PubMed ID: 19492790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of dioxygen catalyzed by pyrene-wired heme domain cytochrome P450 BM3 electrodes.
    Udit AK; Hill MG; Bittner VG; Arnold FH; Gray HB
    J Am Chem Soc; 2004 Aug; 126(33):10218-9. PubMed ID: 15315414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid screening for cytochrome P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives.
    Tsotsou GE; Di Nardo G; Sadeghi SJ; Fruttero R; Lazzarato L; Bertinaria M; Gilardi G
    J Biomol Screen; 2013 Feb; 18(2):211-8. PubMed ID: 22983164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
    Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
    Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subzero-temperature stabilization and spectroscopic characterization of homogeneous oxyferrous complexes of the cytochrome P450 BM3 (CYP102) oxygenase domain and holoenzyme.
    Perera R; Sono M; Raner GM; Dawson JH
    Biochem Biophys Res Commun; 2005 Dec; 338(1):365-71. PubMed ID: 16197919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resonance Raman study on synergistic activation of soluble guanylate cyclase by imidazole, YC-1 and GTP.
    Pal B; Li Z; Ohta T; Takenaka S; Tsuyama S; Kitagawa T
    J Inorg Biochem; 2004 May; 98(5):824-32. PubMed ID: 15134928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.